We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

02 Jun 2025 - 04 Jun 2025
11 Jun 2025 - 13 Jun 2025

First-Ever Rapid-Result Hematology Analyzer Measures Disease and Infection at POC

By LabMedica International staff writers
Posted on 31 Mar 2023

Sepsis is a severe medical emergency that occurs when the body reacts strongly to an infection. More...

This life-threatening condition is triggered by a chain reaction throughout the body, often starting from infections in the lung, urinary tract, skin, or gastrointestinal tract. Nearly any infection can lead to sepsis, which occurs when a localized infection progresses to severe infection throughout the body. According to a 2020 study, sepsis caused almost 11 million deaths worldwide in 2017, accounting for nearly 20% of all deaths in that year. Now, a new rapid-result hematology system comes with the capability to count immature infection-fighting granulocytes, one of the earliest markers for sepsis.

The QScout RLD rapid-result hematology system from Ad Astra Diagnostics, Inc. (AAD, Morrisville, NC, USA) is designed to measure white blood cell count, neutrophil-to-lymphocyte ratio, and counts of six white blood cell types in fingerstick or venous blood. QScout is the first hematology platform designed to quickly and accurately measure disease and infection, including a ratio of two white blood cell types (neutrophil-to-lymphocyte ratio) and count of immature granulocytes, at the point of care.

The QScout system uses a Rapid Leukocyte Differential (RLD) test that contains a dried reagent to stain cells. Whole blood is added to the test and inserted into the QScout Lab analyzer. The analyzer's optical system captures images of the cells, while an algorithm quickly identifies them, and results are displayed within two minutes. Ad Astra has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for the QScout RLD. The company aims to expedite the regulatory review process to obtain clearance for the system's use at the point of care, where faster results can improve health outcomes, and in the lab, where it can enhance efficiency.

“QScout RLD was designed as a quick, quantitative 'scout' for infection that is simple enough to operate yet robust enough to deliver reliable data patient-side,” said AAD's chief scientific officer and co-founder, Rudy Rodriguez. “In doing so, QScout RLD offers the potential to democratize access to quality diagnostics, while providing healthcare professionals with a potentially life-saving tool.”

Related Links:
Ad Astra Diagnostics 


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Respiratory Syncytial Virus Test
OSOM® RSV Test
New
Toxoplasma Gondii Test
Toxo IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: New biomarkers could someday make it easy to spot Parkinson’s disease in a patient’s blood sample (Photo courtesy of Shutterstock)

Unique Blood-Based Genetic Signature Can Diagnose Parkinson’s Disease

Parkinson's disease is primarily recognized for its impact on the central nervous system. Recent scientific progress has shifted focus to understanding the involvement of the immune system in the onset... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: The new tool is designed for accurate detection of structural variations in clinical samples (Photo courtesy of Karen Arnott/EMBL-EBI and Isabel Romero Calvo/EMBL)

ML Algorithm Accurately Identifies Cancer-Specific Structural in Long-Read DNA Sequencing Data

Long-read sequencing technologies are designed to analyze long, continuous stretches of DNA, offering significant potential to enhance researchers' abilities to detect complex genetic changes in cancer genomes.... Read more

Technology

view channel
Image: Concept of biosensor integrated into hygiene pads enabling direct semi-quantitative analysis of biomarkers in unprocessed menstruation blood (Photo courtesy of Dosnon, L et al. DOI: 10.1002/advs.202505170)

First Ever Technology Recognizes Disease Biomarkers Directly in Menstrual Blood in Sanitary Towels

Over 1.8 billion people menstruate worldwide, yet menstrual blood has been largely overlooked in medical practice. This blood contains hundreds of proteins, many of which correlate with their concentration... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.